BioSpace News Archive

7 Passive-Aggressive Phrases to Avoid in Workplace Emails

Unlike face-to-face conversations or even phone calls where you can easily pick up on things like the other person’s tone, intent, and nuance, email communication is often more ambiguous… and problematic.

February 21, 2019

·

3 min read

·

Editorial Staff

Deals

Merck Acquires Immune Design for $300 Million in Cash

Shares of Immune Design are skyrocketing in premarket trading today after Merck announced it will acquire the Seattle-based oncology company for $300 million in cash. Immune Design stock has shot up more than 310 percent to $5.83 in early trading.

February 21, 2019

·

2 min read

·

Alex Keown

Policy

Meet the Pharma Reps About to Face the Senate Over Pricing Concerns

Seven pharma executives will enter the Congressional crucible next week as they face questions and concerns over the rising costs of prescription drugs.

February 21, 2019

·

3 min read

·

Alex Keown

Deals

Recipharm AB publishes its report for the fourth quarter and full year 2018

Recipharm announced the intention to end operations in Ashton-under-Lyne, United Kingdom

February 21, 2019

·

6 min read

Deals

Firmly on our way to becoming a fully integrated biopharma company

FINCH 2 Phase 3 trial with filgotinib in rheumatoid arthritis (RA) met all primary and secondary endpoints, with consistent tolerability

February 21, 2019

·

12 min read

Policy

High Dose of Pfizer’s Xeljanz Raises Red Flag in a Post-Marketing Study

Pfizer’s blockbuster rheumatoid arthritis drug Xeljanz, a JAK inhibitor, has been a strong performer for the company, bringing in $1.77 billion in revenue last year. But now the company has indicated it intends to make a change in its post-marketing study due to safety concerns.

February 21, 2019

·

2 min read

·

Alex Keown

Policy

J&J Hit With Federal Subpoenas Over Baby Powder Contamination Allegations

Johnson & Johnson’s iconic talcum powder product has been the subject of lawsuits and a scathing report that indicated the company allegedly knew that carcinogenic asbestos was sometimes found in the product. As a result, the company has received subpoenas from the federal government.

February 21, 2019

·

2 min read

·

Alex Keown

Bio NC

J&J Earns Spot in Fortune’s Top 50 Most Respected Companies

It’s nice to be admired. Fortune released its list of the most respected companies across the globe and one pharma company made the top 50 list.

February 21, 2019

·

4 min read

·

Alex Keown

Policy

AbbVie and Eisai Announce Fully Human Anti-TNF-alpha Monoclonal Antibody HUMIRA is the First in Japan to be Approved for the Treatment of Hidradenitis Suppurativa

AbbVie announced that they have received approval for an additional indication of HUMIRA, a fully human anti-TNF-alpha monoclonal antibody, for the treatment of hidradenitis suppurativa.

February 21, 2019

·

5 min read

Business

Insilico and Teva enter collaboration to apply predictive Digital Twins for biopharmaceutical production

Insilico Biotechnology AG and Teva Pharmaceutical Industries Ltd. announced an agreement to apply Insilico’s technology for predictive biomanufacturing to create and implement more efficient production processes of Teva’s biopharmaceutical therapeutics.

February 21, 2019

·

3 min read